Nanalysis Scientific (CVE:NSCI) Sets New 12-Month Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s share price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.16 and last traded at C$0.17, with a volume of 598249 shares changing hands. The stock had previously closed at C$0.18.

Nanalysis Scientific Stock Performance

The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72. The company’s fifty day moving average is C$0.19 and its 200 day moving average is C$0.22. The company has a market cap of C$20.09 million, a P/E ratio of -1.59 and a beta of -0.82.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Further Reading

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.